Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
24,685,905
-
Share change
-
+2,446,455
-
Total reported value
-
$3,051,928,179
-
Put/Call ratio
-
257%
-
Price per share
-
$123.62
-
Number of holders
-
193
-
Value change
-
+$312,101,188
-
Number of buys
-
104
-
Number of sells
-
93
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2020
As of 31 Dec 2020,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,685,905 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, CPMG Inc, VANGUARD GROUP INC, Invesco Ltd., FRANKLIN RESOURCES INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Duquesne Family Office LLC, Corriente Advisors, LLC, and Cormorant Asset Management, LP.
This page lists
193
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.